Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
靶向半胱氨酸输入诱导胰腺癌铁死亡细胞
基本信息
- 批准号:10446758
- 负责人:
- 金额:$ 40.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-08 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:4&apos-phosphopantetheineAcuteAllelesAmino AcidsAntioxidantsAutophagocytosisBasic ScienceBiochemical GeneticsCancer EtiologyCell DeathCell LineCellsCellular MembraneCessation of lifeChemistryCoenzyme ACystCysteineCystineCytotoxic ChemotherapyDataDetoxification ProcessDietDisulfidesDrug Metabolic DetoxicationElectronsEngineeringEnzymesFDA approvedFerritinGenerationsGeneticGenetic EngineeringGenetically Engineered MouseGlutamatesGoalsGrantHumanHypoxiaImmunotherapyIntercellular FluidInterruptionIronKRAS2 geneKnockout MiceLipidsMEK inhibitionMEKsMalignant Epithelial CellMalignant NeoplasmsMalignant neoplasm of pancreasMammalian CellMediatingMembraneMembrane LipidsMetabolismMethodsModelingMolecular BiologyMusMutant Strains MiceMutationNecrosisNormal CellOncoproteinsOxidation-ReductionOxidative StressOxidesPancreatic Ductal AdenocarcinomaPathway interactionsPatientsPharmaceutical PreparationsPharmacologyPhenocopyPhenotypePhysiologicalPolyunsaturated Fatty AcidsProcessProductionPropertyProteinsReactionReactive Oxygen SpeciesRegimenResistanceRoleRuptureSamplingScienceSideSourceStable Isotope LabelingSulfhydryl CompoundsSystemSystems BiologyTP53 geneTechniquesTestingTissuesTumor ImmunityUnited StatesWaterWorkanti-cancerantiporterclinical translationcomparative efficacydetoxicationdietaryextracellularimprovedin vivoinhibitormacromoleculemortalitymouse modelmutantnoveloxidative damagepancreatic cancer cellspancreatic ductal adenocarcinoma cellpancreatic ductal adenocarcinoma modelpancreatic neoplasmperoxidationpreclinical efficacypreventprogramsrecombinaseresponsesemi essential amino acidtargeted treatmenttherapeutic targettherapeutically effectivetranslational approachtumortumor metabolismtumor microenvironmentuptake
项目摘要
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal human malignancies and is responsible for
over 48,000 deaths per year in the United States. PDAC tumors have several genetic and physiological
properties that promote the generation of highly toxic reactive oxygen species (ROS), which can interact
destructively with cellular macromolecules. As a result, these tumors rely heavily on ROS detoxification programs
which employ thiol groups to mitigate the electron imbalances that define ROS. Those thiols are ultimately
derived from cysteine, a semi-essential amino acid with a thiol-containing side chain. As cysteine is ultimately
sourced from dietary sources, the import of exogenous cysteine is a critical step in the ROS detoxification
process. In the first term of this grant, we tested the hypothesis that PDAC depends on cysteine import for
survival. We found that depletion of cysteine, either through depletion from the media or by inhibition of cysteine
uptake, resulted in the induction of ferroptosis, a form of regulated necrosis that occurs due to oxidative damage
to cellular membranes. We demonstrated that cysteine depletion could selectively induce ferroptosis in PDAC
tumors in vivo using both genetic and pharmacological approaches and we expanded the mechanistic
understanding of ferroptosis by demonstrating that depletion of coenzyme A (a cysteine derivative) is necessary
for the induction of ferroptosis in pancreatic tumor cells.
Here we will extend these findings in order to potentiate the effects of cysteine depletion in PDAC. First, we
will study the mechanistic difference between inhibition of system xC– versus degradation of exogenous cystine
with the engineered enzyme cyst(e)inase. We will then directly compare the preclinical efficacy of these
approaches in a genetically engineered models of PDAC, making use of a new, highly potent system xC– inhibitor.
Second, we will pursue our earlier findings on the role of coenzyme A in regulating ferroptosis by studying
whether high levels of coenzyme A in the tumor microenvironment might help suppress ferroptosis in malignant
epithelial cells. This leads to a strategy of targeting ENPP proteins, which are necessary for the (indirect) import
of exogenous coenzyme A. Third, we will determine whether the release of free iron from ferritin through via
autophagy can promote ferroptosis in the context of cysteine depletion. This leads to a strategy of activating
autophagy via MEK inhibition to increase lipid ROS production and sensitize to ferroptosis in combination with
cysteine depletion. For each of these topics, we will pursue both basic science mechanisms and translational
strategies. The studies will make use of genetically engineered mouse models of PDAC as well as novel tumor
explant models developed by our group in which human or murine PDAC samples are cultured intact in an
engineered system for up to a week. Together, these studies will further elucidate the mechanisms of response
to cysteine-depletion strategies in pancreatic ductal adenocarcinoma.
摘要:
胰腺导管腺癌(PDAC)是人类最致命的恶性肿瘤之一,与
在美国,每年有超过4.8万人死亡。PDAC肿瘤有几种遗传学和生理学特征
促进产生剧毒的活性氧物种(ROS)的特性,这种ROS可以相互作用
对细胞大分子具有破坏性。因此,这些肿瘤严重依赖ROS解毒计划。
它们使用硫醇基团来缓解定义ROS的电子不平衡。这些硫醇最终是
来源于半胱氨酸,一种半必需氨基酸,含有硫醇侧链。因为半胱氨酸最终会
从饮食来源进口外源半胱氨酸是ROS解毒的关键一步
进程。在这笔赠款的第一个任期内,我们测试了PDAC依赖半胱氨酸进口的假设
生死存亡。我们发现半胱氨酸的耗尽,要么是通过从介质中耗尽,要么是通过抑制半胱氨酸
摄取,导致铁下垂的诱导,这是一种由于氧化损伤而发生的调节性坏死形式
到细胞膜。我们证明半胱氨酸的耗竭可以选择性地诱导PDAC的铁性下垂。
体内肿瘤的遗传和药理学方法,我们扩大了机制
通过证明辅酶A(一种半胱氨酸衍生物)的耗竭是理解铁性下垂的必要方法
用于诱导胰腺肿瘤细胞铁性下垂。
在这里,我们将扩展这些发现,以加强半胱氨酸耗竭对PDAC的影响。首先,我们
将研究抑制XC-系统和降解外源半胱氨酸之间的机理差异
用工程化酶包囊(E)酶。然后我们将直接比较这些药物的临床前疗效
在PDAC的基因工程模型中,利用一种新的、高度有效的系统XC-抑制剂的方法。
其次,我们将通过研究来继续我们早先关于辅酶A在调节铁性下垂中的作用的发现
肿瘤微环境中高水平的辅酶A是否有助于抑制恶性肿瘤患者的铁下垂
上皮细胞。这导致了以ENPP蛋白质为靶点的策略,这些蛋白质是(间接)进口所必需的
外源辅酶A。第三,我们将确定铁蛋白通过
在半胱氨酸耗竭的情况下,自噬可以促进铁性下垂。这导致了一种激活策略
通过抑制MEK自噬增加脂质ROS的产生并联合应用增敏铁性下垂
半胱氨酸耗尽。对于这些主题中的每一个,我们都将研究基础科学机制和翻译
战略。这些研究将利用基因工程小鼠的PDAC模型以及新的肿瘤
本课题组建立的外植体模型中,人或小鼠的PDAC样本在
长达一周的工程系统。总之,这些研究将进一步阐明反应的机制。
胰腺导管腺癌的半胱氨酸耗竭策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kenneth P Olive其他文献
Sa1716 The Murine Kpc- Pancreatic Cancer Model Accurately Resembles “Neural Remodeling” Seen in Human Chronic Pancreatitis and Pancreatic Cancer
- DOI:
10.1016/s0016-5085(13)61029-x - 发表时间:
2013-05-01 - 期刊:
- 影响因子:
- 作者:
Bernhard W Renz;Christoph B. Westphalen;Daniel L. Worthley;Samuel Asfaha;Xiaowei Chen;Helen Remotti;Michael Quante;Kenneth P Olive;Timothy C. Wang - 通讯作者:
Timothy C. Wang
Kenneth P Olive的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kenneth P Olive', 18)}}的其他基金
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
靶向半胱氨酸输入诱导胰腺癌铁死亡细胞
- 批准号:
10590731 - 财政年份:2017
- 资助金额:
$ 40.94万 - 项目类别:
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
靶向半胱氨酸输入诱导胰腺癌铁死亡细胞
- 批准号:
10088424 - 财政年份:2017
- 资助金额:
$ 40.94万 - 项目类别:
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
靶向半胱氨酸输入诱导胰腺癌铁死亡细胞
- 批准号:
9289422 - 财政年份:2017
- 资助金额:
$ 40.94万 - 项目类别:
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
胰腺癌平滑抑制的基质反应机制
- 批准号:
8591387 - 财政年份:2011
- 资助金额:
$ 40.94万 - 项目类别:
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
胰腺癌平滑抑制的基质反应机制
- 批准号:
8084639 - 财政年份:2011
- 资助金额:
$ 40.94万 - 项目类别:
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
胰腺癌平滑抑制的基质反应机制
- 批准号:
8403907 - 财政年份:2011
- 资助金额:
$ 40.94万 - 项目类别:
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
胰腺癌平滑抑制的基质反应机制
- 批准号:
8232091 - 财政年份:2011
- 资助金额:
$ 40.94万 - 项目类别:
相似海外基金
MYCOBACTERIUM TUBERCULOSIS PHOSPHOPANTETHEINE ADENYLTRANSFERASE
结核分枝杆菌磷酸泛硫氨酸腺苷酸转移酶
- 批准号:
7182516 - 财政年份:2005
- 资助金额:
$ 40.94万 - 项目类别: